Navigation Links
Innovative Therapies Inc (ITI) Announces New Executive Management Team of the Wound Care Therapy Division and New User Friendly Website
Date:2/26/2013

GAITHERSBURG, Md., Feb. 26, 2013 /PRNewswire/ -- Innovative Therapies Inc (ITI) announced today it has launched a new website (www.itimedical.com) and appointed a new executive management team for the negative pressure wound therapy division.

Richard Vogel , CEO, founded ITI in 2006 and has served as ITI's full-time President and CEO since 2008.  Richard has held CEO/President/COO and General Manager positions at several medical device, pharmaceutical, and biotech companies such as Kinetic Concepts, Inc. and American Cyanamid Company. 

Dave Tumey , Chief Technology Officer (CTO), has 24 years experience in the field of biomedical R&D, including Director of V.A.C. R&D at Kinetic Concepts Inc. (KCI). Dave has fifty-four issued patents with many others pending, and has a background in electrical engineering.

Matt Dambeck , Chief Operating Officer (COO), recently joined Innovative Therapies from Stryker and is responsible for operations, sales and clinical service delivery. He has 10 years' experience in the medical device industry, most recently as an Area Director of Sales.

Sandra Berriman , Ph.D., Vice President of Medical Affairs, has over 18 years experience in advancing pharmaceutical and medical device entities into the healthcare marketplace. While at Pfizer, her clinical team developed and launched Toviaz, as well as scientifically supported Detrol LA and Viagra.  

Christine Grogan , Vice President of Marketing, has over 20 years of healthcare experience in medical and consumer marketing, sales, sales training and management at Allergan, Pfizer, and Parke Davis .  She has held key leadership roles as Director of Botox and Senior Director of Breast Implants at Allergan. Christine stated that this new website would be invaluable to health care providers in the wound care space as well as for patients looking for more information about the benefits of negative pressure wound therapy.

Richard Vogel stated that "This newly appointed executive team has vast experience in launching blockbuster medical products, and is committed to ensuring that patients in the wound care space get the best therapy that this field can offer."


'/>"/>
SOURCE Innovative Therapies Inc
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
2. Innovative MetaMorph® NX Software Shatters Barriers Between Researchers and Image Analysis Goals with Exclusive Visual Workflow
3. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
4. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
5. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
6. FasterCures Spotlights Addario Lung Cancer Medical Institutes Innovative Research Programs
7. ZyGEM Teams With TATAA Biocenter To Distribute Its Innovative Nucleic acid Extraction Kits
8. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
9. Stanford faculty awarded $2.2 million for innovative energy research
10. Collegiate Inventors Honored for Innovative Science and Technology Advances
11. France & Germany Blood Banking Market: Innovative Technologies and Emerging Business Opportunities in New Research Report at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... Scientists at the ... options being tried for mesothelioma may be hampering the research that could lead to ... Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Food and Drug Administration (FDA) has granted the company’s orphan drug designation request ... second orphan drug designation granted by the FDA. , Spinocerebellar ataxia is ...
(Date:5/24/2016)... ... ... Last week, Callan Capital, an integrated wealth management firm specializing in asset ... Diego Life Science event at the Estancia La Jolla Resort and Spa. , Over ... Dr. Rich Heyman, former CEO of Aragon and Seragon, and Faheem Hasnain, former CEO ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® ... Farming in 2017 and Beyond. The paper outlines the key trends that are ... industry. , “We’ve witnessed a lot of highs and lows as the precision ...
Breaking Biology Technology:
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):